$27.59
3M Ago | 1M Ago | Current | |
Buy | 11 | 11 | 11 |
Outperform | 9 | 9 | 9 |
Hold | 3 | 3 | 3 |
Underperform | 0 | 0 | 0 |
Sell | 0 | 0 | 0 |
The latest share price target for Denali Therapeutics Inc (DNLI) is $40.77, offered by 23 analysts offering 12-month price forecasts.
Denali Therapeutics Inc (DNLI) has a maximum of 0.48 upside potential, based on 23 analysts offering 12-month price forecasts.
Based on 23 analysts tracking and researching Denali Therapeutics Inc (DNLI), 86.96% have a buy recommendation. Remaining 13.04% have either sell or hold recommendations.
The latest share price of Denali Therapeutics Inc (DNLI) is $27.59 as of 21/10/2024.
20 of total 23 analysts offering stock ratings for Denali Therapeutics Inc DNLI have recommended buy rating.